Edit Remák MSc PhD

Edit ‘s main areas of interest are economic modelling and pricing. She has experience in developing many different model types (cohort and patient level simulation models), serving different aims (cost-effectiveness models, budget impact models, pricing models, tools used for on-site negotiations), for different audiences (regulatory bodies, expert communities, internal decision makers). Prior to joining Visible Analytics, she was a Senior Research Leader in the Modelling and Simulation group Evidera for over 17 years.

Edit has been involved in the preparation of a number of evidence submissions for the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), the National Centre for Pharmacoeconomics (NCPE) in Ireland, the Tandvårds- och Läkenedelsförmånsverket (TLV) in Sweden and many similar bodies in other countries. She has also coordinated multinational studies, prepared manuscripts, and training for pharmaceutical companies in the use and interpretation of models for cost effectiveness.

She has extensively published in journals such as the Journal of Clinical Oncology, European Journal of Health Economics, British Journal of Cancer, and Journal of Medical Economics.

Edit completed a PhD in Health Economics in 2015 at Brunel University and and MSc in Health Economics (with distinction) at the University of York.